hormone therapy is the treatment of choice, rather than surgery. Surgery to reduce hormone levels may only be offered if the cancer has spread to other areas or is in a more advanced stage.
Hormone therapy for prostate cancer is also known as androgen deprivation therapy (ADT). cannot grow or survive without , which include and other male hormones. Hormone therapy decreases the amount of androgens in a man's body. Reducing androgens can slow the growth of the cancer and even ...
Hormone therapy for prostate cancer: What have we done with Charles Huggin's legacy? European Urology, 61(1), 26-28. doi: http://dx.doi.org/10.1016/j.eururo.2011.09.005Bertrand, Tombal. (2012) Hormone Therapy for Prostate Cancer: What Have We Done With Charles Huggins’ Legacy?. ...
Hormone-targeted treatment has previously been linked to a higher risk of diabetes and heart disease. Azoulay and his colleagues took UK data on 10,250 men who were diagnosed with prostate cancer between 1997 and 2008. The men were followed for an average of just over four years after their ...
It has been known for more than two centuries that the growth of the normal prostate and its malignancies is dependent upon hormonal function [9, 26, 68]. More recently, the application of this knowledge to the management of advanced prostate cancer has been rationalized, building upon the ...
(HealthDay)—Hormone therapy for prostate cancer might dramatically increase a man's risk of developing Alzheimer's disease, a large-scale analysis of health data suggests.
It can be arise prostate cancer Loss of libido, Sexual dysfunction. Poor concentration Accumulation of fat. Loss of muscle mass Osteopenia or osteoporosis etc. The above mentioned some disease can occur when a man has a problem of androgen (misbalance of hormones). The low level and high leve...
New research has found that hormone therapy used to treat men with advanced prostate cancer is associated with an increased chance of developing various heart problems. Some choices of therapy appear, however, to be less risky than others. ...
Prostate cancerRadiorecurrenceHormone therapyIndustry SectorsBiotechnologyHealth &HospitalsPharmaBACKGROUND: The management of patients who relapse after radical radiotherapy is a challenging problem for the multidisciplinary team. This group of men may have been considered ineligible or chosen not to be ...
Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing the cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur. ...